Your browser doesn't support javascript.
loading
The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level.
Ben Sahra, I; Laurent, K; Loubat, A; Giorgetti-Peraldi, S; Colosetti, P; Auberger, P; Tanti, J F; Le Marchand-Brustel, Y; Bost, F.
Affiliation
  • Ben Sahra I; INSERM U568, Nice, France.
Oncogene ; 27(25): 3576-86, 2008 Jun 05.
Article in En | MEDLINE | ID: mdl-18212742
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Gene Expression Regulation, Neoplastic / Cyclin D1 / Metformin / Antineoplastic Agents Limits: Humans / Male Language: En Journal: Oncogene Journal subject: BIOLOGIA MOLECULAR / NEOPLASIAS Year: 2008 Document type: Article Affiliation country: Francia Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Gene Expression Regulation, Neoplastic / Cyclin D1 / Metformin / Antineoplastic Agents Limits: Humans / Male Language: En Journal: Oncogene Journal subject: BIOLOGIA MOLECULAR / NEOPLASIAS Year: 2008 Document type: Article Affiliation country: Francia Country of publication: Reino Unido